Journal article
Cutaneous leukocytoclastic vasculitis associated with letrozole.
- Digklia A Centre Pluridisciplinaire d'Oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
- Tzika E
- Voutsadakis IA
- 2013-05-17
Published in:
- Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. - 2014
Aromatase inhibitors
breast cancer
cutaneous vasculitis
letrozole
skin adverse effects
Aged
Antineoplastic Agents
Aromatase Inhibitors
Breast Neoplasms
Female
Humans
Letrozole
Nitriles
Triazoles
Vasculitis, Leukocytoclastic, Cutaneous
English
Aromatase inhibitors are increasingly used in the treatment of early and metastatic breast cancer. They can produce various skin adverse effects but are only rarely associated with cutaneous vasculitis. We report the first case of cutaneous vasculitis clearly associated with the use of aromatase inhibitor letrozole.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1177/1078155213480535
- PMID 23676512
- Persistent URL
- https://sonar.ch/global/documents/161753
Statistics
Document views: 54
File downloads: